MedPath

R35 CHADONTIN LIQ

R35 CHADONTIN LIQ

Discontinued
DIN Number

00864609

Drug Class

Human

Market Date

Dec 31, 1989

Company
HC

dr reckeweg and co

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number00864609
AIG Number0622010001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Homeopathic
Product Specifications
Dosage FormDrops
Route of AdministrationOral
AHFS Classification92:02.00*
Health Canada Classification

ACTIVE INGREDIENTS (6)

ACONITEActive
Strength: 6 D / D
Monograph: ACONITE
BRYONIAActive
Strength: 30 D / D
Monograph: BRYONIA
CALCIUM CARBONATEActive
Strength: 30 D / D
Monograph: CALCIUM CARBONATE
CHAMOMILEActive
Strength: 4 D / D
Monograph: CHAMOMILE
CITRULLUS COLOCYNTHISActive
Strength: 12 D / D
Monograph: CITRULLUS COLOCYNTHIS
DELPHINIUM STAPHISAGRIAActive
Strength: 8 D / D
Monograph: DELPHINIUM STAPHISAGRIA

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.